CTT Pharmaceutical Holdings, Inc. has announced a significant change in its financial oversight. The company has appointed Zhanna Kelley, CPA, as its new PCAOB Auditor after the resignation of its previous auditor, Holt & Patterson. This transition is crucial as it reflects the company's commitment to maintaining rigorous financial reporting standards.

The change in auditors comes at a pivotal time for CTT Pharmaceutical Holdings, which operates in the pharmaceutical preparations industry. The resignation of Holt & Patterson was confirmed not to be due to any disagreements regarding accounting practices, which may help ease concerns among investors and stakeholders.

CTT Pharmaceutical Holdings, Inc., based in Tampa, Florida, is classified under the SIC code 2834, which pertains to Pharmaceutical Preparations. The company trades on the OTC market under the ticker symbol CTTH. Recent filings show that the company has been active in updating its financial practices, indicating a focus on compliance and transparency.

In the latest filing dated October 30, 2026, CTT reported that it signed an engagement letter with Zhanna Kelley, CPA, on October 27, 2026. This move is expected to enhance the company's financial oversight and align its auditing practices with industry standards.

CTT's shift in auditors may have implications for its stakeholders, including investors and regulatory bodies. The appointment of a new PCAOB Auditor signifies a potential change in the company's approach to financial reporting and compliance. It also highlights the importance of maintaining investor confidence in a highly regulated industry.

Looking ahead, CTT Pharmaceutical Holdings may continue to provide updates on its financial practices as it adapts to this new oversight. The filing does not specify any immediate next steps beyond the auditor change.